news
NIH begins testing Ebola treatment in early-stage trial
Scientists developed monoclonal antibody from Ebola survivor...
List view / Grid view
Antibodies
news
Eczema drug effective against severe asthma
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies...
news
Organ-chips model and predict thrombotic side effect caused by anti-CD154 antibody hu5c8
An Emulate, Inc. study has demonstrated that its Blood Vessel-Chip accurately modelled and predicted thrombosis, or clotting of blood, induced by certain monoclonal antibody drugs, specifically anti-CD154 monoclonal antibody (mAb) hu5c8.
article
Biopharma Processing & Development In-Depth Focus 2018
In this In-Depth Focus; enabling the manufacture of robust biologic drug products, automating biopharmaceutical development, and greater compatibility and ease of use for bioproduction monitoring of monoclonal antibodies.
news
Antigen study provides a new approach to vaccine development for RSV
Medical researchers point to a promising route for designing an effective vaccine for the respiratory syncytial virus...
news
Waters New ACQUITY Arc Bio System brings advanced method transfer capabilities to routine bioseparations
Waters Corporation (NYSE:WAT) today introduced the Waters® ACQUITY™ Arc™ Bio System, a versatile, iron-free, bio-inert, quaternary liquid chromatograph specifically engineered to enable the efficient transfer and improvement of bioseparation analytical methods regardless of the LC platform on which the original method was developed...
news
Waters BioResolve RP mAb Polyphenyl Columns, setting a new standard for reversed-phase separations of Monoclonal Antibodies and Antibody Drug Conjugates
Waters Corporation (NYSE:WAT) today introduced BioResolve™ RP mAb Polyphenyl 450 angstrom 2.7 micron solid core Columns intended for the reversed-phase analysis of intact or sub-unit-digested monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) using LC-UV and LC-MS...
news
Heroin vaccine could tackle opioid addiction
New research shows that experimental vaccine produces antibodies against commonly misused opioids, including heroin, hydrocodone, oxycodone, hydromorphone, oxymorphone and codeine.
news
New Lyme disease tests could offer quicker, more accurate detection
New tests to detect early Lyme disease - which is increasing beyond the summer months - could replace existing tests that often do not clearly identify the infection before health problems occur.
webinar
Application of HDX-MS for drug discovery and development
13 October 2017 | By Thermo Fisher Scientific
In this webinar, theory and practice of HDX-MS will be discussed in conjunction with the topics of pharmaceutical industry...
news
Join Dolomite Bio at ASHG 2017
Dolomite Bio is set to display its innovative range of products for high throughput single cell research at the 67th Annual Meeting of the American Society of Human Genetics (ASHG), taking place at the Orange County Convention Center in Orlando, Florida, from the 17th to the 21st of October 2017...
news
EC grants marketing authorisation of Dupixent for atopic dermatitis
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that the EC has granted marketing authorisation for Dupixent for use in adults with moderate-to-severe atopic dermatitis...
whitepaper
Poster: Accelerate antibody drug development with subdomain-specific affinity ligands
Scientists from Thermo Fisher Scientific discuss how the CaptureSelect affinity purification products and analytical tools have been developed for the discovery and manufacturing of therapeutic antibodies, including novel formats such as bi-specific antibodies and Fc-fusion proteins...
whitepaper
Poster: Optimised purity and recovery of a monoclonal antibody using mixed-mode chromatography media
Bio-Rad discuss the technique of optimising the purity of a monoclonal antibody using mixed-mode chromatography media...
article
Personalised medicine, batch size of ONE, the new challenge to fill-finish?
Wenzel Novak PhD gives some considerations on container, environment, process and automation for small batch sizes in the downstream process of fill-finish…
